Evidence map›Paper›PMID 42570237›Full record

ArticleCell reports2026

PKR engages viral RNA and intron-retained host transcripts during poxvirus infection.

Ruilin Zhang, Xiang Ye, Andrew C Dixson, Yang Zhao, Alissa M Weaver, John Karijolich

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruilin ZhangDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt Center for Immunobiology, and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, TN 37232-2363, USA.
Xiang YeDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt Center for Immunobiology, and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, TN 37232-2363, USA.
Andrew C DixsonDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA.
Yang ZhaoDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt Center for Immunobiology, and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, TN 37232-2363, USA.
Alissa M WeaverDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt Center for Immunobiology, and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, TN 37232-2363, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA; Vanderbilt Center for Extracellular Vesicle Research, Nashville, TN 37232-2363, USA.
John KarijolichDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt Center for Immunobiology, and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, TN 37232-2363, USA; Department of Biochemistry, Vanderbilt University, Nashville, TN 37232-2363, USA. Electronic address: john.karijolich@vumc.org.

Funding

Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
Cellular, Biochemical and Molecular Sciences Training ProgramT32GM137793 · NIGMS · VANDERBILT UNIVERSITY · PI Katherine Louise Friedman, TODD R GRAHAM · 2021 to 2026
$2.6M
Cell Intrinsic Immune Control of KSHVR01AI141448 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARIJOLICH, JOHN · 2020 to 2024
$2.1M
(PQ#2) Transposable element-mediated gene regulation in KSHV-associated cancerR01CA250051 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARIJOLICH, JOHN · 2020 to 2024
$2.1M
Restriction of KSHV by cellular RNA decay pathwaysR01CA278642 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Karijolich · 2023 to 2026
$1.6M
NCI NIH HHS P01 CA229123NCI NIH HHS R01 CA250051NCI NIH HHS R01 CA278642NIAID NIH HHS R01 AI141448NIGMS NIH HHS T32 GM137793
6 · The paper itself

Abstract

Recognition of double-stranded (ds) RNA is central to antiviral defense, yet how RNA sensors are activated during infection remains unclear. Here, we demonstrate that during vaccinia virus (VacV) infection, PKR binding is enriched on viral RNAs and host-intron-containing transcripts. During infection, RNase L activation impaired pre-mRNA splicing, promoting accumulation of cytoplasmic intron-retaining transcripts. Small-molecule inhibition of splicing activated PKR independently of RNase L, supporting defective pre-mRNA splicing as a source of PKR ligands. PKR also engaged structured viral RNAs, including telomere-derived species with distinct activating properties. PKR signaling was further shaped by the cellular RNA-binding protein PACT, which enforces a dsRNA abundance threshold for activation, and suppressed by the viral antagonist E3. These findings reveal that PKR monitors both virus-derived and processing-defective host RNAs during infection, establishing cooperativity at the intersection of RNA processing, viral replication, and innate defense.

Indexed as

antiviral immunityCP: immunologyCP: molecular biologydsRNAOASPKRpoxvirusRNase Lvaccinia virus

Identifiers

PMID42570237
PMCPMC13587633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.